Heartworm
Dogs
Heartworm
Heartworm is a
parasitic
roundworm (Dirofilaria immitis) that is spread from
host to host through the bites of
mosquitoes. The heartworm affects
dogs,
cats,
wolves,
coyotes,
foxes, and
some other animals, such as
ferrets,
sea
lions, and even
humans.
The parasitic worm is called a "heartworm" because the parasite, in the
final reproductive stage of its
life cycle, resides in the
heart of
its host where it can stay for many years, until it kills its host
through
congestive failure of the heart.
History of the disease
Heartworm was first discovered in dogs over a century ago and documented in
cats by the 1920s. Since then, diagnostic tests and treatments for heartworm as
well as preventative measures have been developed. Heartworm
infestation may be extremely serious for the infected host; infected dogs
that go untreated can die and even treated dogs must go through a long period of
uncomfortable treatment (sometimes requiring
surgery) to
kill the worms and remove them from the body. The best defense against heartworm
is the use of
prophylactic treatment given regularly during the mosquito season.
A course of heartworm prevention begins with a
blood test to see
if the parasite
is present. If the dog is parasite free, a prophylactic medication can be used
to prevent heartworm infection. A positive test result, on the other hand,
usually requires treatment to eradicate the worms.
Heartworm in North America
Although at one time confined to more southern
climates,
heartworm has now spread to nearly all climates where its
vector, the mosquito, occurs (a vector is an intermediate host for
the developing parasite, that spreads the disease from host to host).
Transmission of the parasite from dog to dog occurs in all of the
United States (except Alaska) and the warmer regions of
Canada. The
highest infection rates in North America occur in dogs within 150 miles of the
Atlantic and
Gulf coasts and along the
Mississippi River and its major tributaries. However, high rates of
infections are found in any area with large mosquito populations.
The parasite
Microfilaria
Heartworms go through several
life stages before they become adults infesting the heart of the host
animal. The worms require the mosquito as an intermediate stage in order to
complete their life cycle and so at least two animal hosts other than the
mosquito are required for the heartworm to reproduce. A mosquitoe ingests
heartworm larvae,
called microfilariae, from an infected host. The mosquitoe then transfers the
larvae to another uninfected host when next it feeds. The microfilariae then go
through several changes to reach adult form, eventually traveling to the right
side of the heart to
reproduce.
Reproduction results in the dispersal of microfilariae into the bloodstream
where ingestion by another feeding mosquito spreads the microfilariae to another
host.
At this stage, the host dog will likely be
asymptomatic. Once the infestation reaches a certain concentration in the
lungs, the now adult worms migrate from the
pulmonary artery to the right side of the heart and begin to reproduce in
ernest, filling the blood with microfilariae. At this point the host will begin
to show symptoms of infestation. These symptoms can manifest earlier or increase
in severity depending on the activity level of the animals as infestation
reduces cardio-pulmonary
capacity. Very active animals may experience symptoms at lower heartworm
concentrations and have more severe symptoms than less active animals.
Heartworms can reach up to 12 inches in length and can remain in the host's
heart for several years.
Course of infestation
The period between the initial infection when the dog is bitten by a mosquito
and the maturation of the worms into adults living in the heart takes some 6.5
to 7 months in dogs and is known as the prepatent period.
Heartworms bear live young, known as microfilariae, producing thousands of
them every day. The microfilariae then circulate in the bloodstream for as long
as two years, waiting for the next stage in their life cycle in the gut of a
bloodsucking mosquito. When ingested by a mosquito, the microfilariae undergo a
series of molts to
the infective, or third, larval stage and then migrate to the head of the
mosquito, where they wait to infect another host. These changes can occur in as
little as two weeks and as long as six weeks, depending on the warmth of the
climate, and generally cease entirely at ambient temperatures below 14° Celsius
(57° Farenheit).
After infection, the third stage larval heartworms deposited by the mosquito
grow for a week or two and molt to the fourth larval stage under the skin at the
site of the mosquito bite. Then they migrate to the
muscles of the
chest and
abdomen and,
some 45 to 60 days after infection, molt to the fifth stage (immature adult).
Between 75 and 120 days after infection these immature heartworms then enter the
bloodstream and are carried through the heart to lodge in the arteries of the
lungs. Over the next 3 to 4 months they increase greatly in size, growing
backwards until they fill the right
atrium and
ventricle
of the heart. By approximately 6.5 to 7 months after infection the adult worms
have mated and the females begin producing microfilariae.
Symptoms of infestation
Dogs show no indication of heartworm infestation during the 6 month long
prepatent period prior to the worms' maturation, and current diagnostic tests
for the presence of microfilariae or
antigens
cannot detect prepatent infections. Rarely, migrating heartworm larvae get
"lost" and end up in unusual sites such as the eye, brain, or an artery in the
leg, which results in unusual symptoms such as blindness,
seizures and
lameness.
Many dogs will show little or no sign of infection even after the heartworms
have matured. To some degree these dogs may be described as seeming to age
slightly faster than normal as the worms slowly damage the lungs,
kidneys and
liver. These
animals usually have a light infection and live a fairly sedentary lifestyle.
However, active dogs and those with heavier infections will quickly show the
classic symptoms of heartworm disease. Early symptoms include a cough,
especially on exercise, and early exhaustion upon exercise. More advanced cases
progress to severe weight loss,
fainting,
coughing up blood, and, finally, congestive heart failure.
Epidemiology
Heartworm is present on every continent except
Antarctica,
where the mosquito vector is noticeably absent. The presence of heartworm in a
geographic region is dependent on the following factors:
- susceptibility of host population
- stability of the
disease reservoir
- population stability of vector species
- proper climate conditions
Dogs are considered the definitive susceptible host for the parasite.
Untreated dogs also provide a stable disease reservoir. (Cats, on the other
hand, are considered a resistant host and a poor disease reservoir. However,
cats are more difficult to treat and so prevention is even more critical with
felines.) Mosquitoes of several different species are the vectors. Development
of the microfilariae in the mosquito ideally requires a temperature at or above
80° Fahrenheit for about two weeks. No larval development takes place in the
mosquito below 57° F.
Testing
Heartworms can be detected by
blood test.
The filtration test finds
microfilariae in the blood; the occult tests (antigen
and antibody)
are used to detect adult worms. Many
veterinarians prefer to do both tests, since the absence of microfilariae in
the blood does not necessarily mean that there are no adult worms in the heart.
Both tests are done with a single blood draw, preferably in the early spring
before daily temperatures warm above 57° F.
X-ray
radiographs and, to a lesser extent,
ultrasound
can also detect the presence of adult heartworms in the heart and lungs. X-rays
also can provide a good estimate of the amount of lung damage caused by the
presence of heartworms.
Treatment
If either a blood test or the onset of symptoms betray the presence of
heartworms, treatment is indicated. Treatment is highly efficacious if the
disease is diagnosed early in the disease process. Before the worms can be
treated, however, the dog must be evaluated for good heart, liver, and kidney
function to ensure the animal can survive the treatment. Any insufficiencies in
these organs must be dealt with first, before treatment, as the eradication
process can be taxing on organ function. Usually the adult worms are killed with
an arsenic-based
compound. The currently recommended compound,
Melarsomine dihydrochloride, is marketed under the brand name
Immiticide. It has a greater efficacy and fewer side effects than
previous formulation (Thiacetarsamide
sodium, sold as
Caparsolate) which makes it a safer alternative for dogs with late-stage
infestations.
After treatment, the dog must rest (restricted exercise) for several weeks so
as to give its body sufficient time to absorb the dead worms without ill effect.
Otherwise, when the dog is under exertion, dead worms may break loose and travel
to the lungs, potentially causing
respiratory failure and death.
Aspirin can
be used during this time to help prevent further arterial damage and
thromboembolism.
The course of treatment is not completed until several weeks later when the
microfilariae are dealt with in a separate course of treatment. Once heartworm
tests come back negative, the treatment is considered a success.
Surgical removal of the adult heartworms is also a treatment that may be
indicated, especially in advanced cases with substantial heart involvement.
Long term monthly administration of
ivermectin
(but apparently not
moxidectin,
milbemycin or
selamectin)
year round for at least three years at the dose normally used for heartworm
prevention (see "Prevention") also
removes most adult heartworms from most dogs. However, this is not the treatment
of choice for removal of adult heartworms for two reasons. First, not all dogs
are completely cleared of heartworms by this treatment. More importantly, adult
heartworms do not begin to die until some 18 months of treatment have elapsed,
which is not acceptable under most circumstances. This treatment is normally
reserved for dogs that are not likely to tolerate treatment with the harsher,
but more effective, melarsomine or instances where the owner cannot afford the
more expensive melarsomine treatment.
From time to time various "homeopathic,"
"natural" or "organic"
products are touted as cures or preventives for heartworm disease. However, such
products have never been proven effective by rigorous scientific methods, and
the claims should be viewed with skepticism.
Prevention
Prevention of heartworm infection can be obtained through a number of
veterinary drugs. Most popular are
ivermectin
(sold under the brand name
Heartgard),
milbemycin (Interceptor) and moxidectin (ProHeart)
administered as pills or chewable tablets. These drugs are given monthly during
the local mosquito season. Moxidectin is also available in a six-month sustained
release injection administered by veterinarians, but the injectable form of
Moxidectin was taken off the market in the United States due to safety concerns.
Selamectin
(Revolution), on the other hand, is a topical preventive that is likewise
administered monthly. Some of these drugs also kill other parasites, including
intestinal worms. In addition, Selamectin controls
fleas,
ticks, and mites.
Preventative drugs are highly effective, and when regularly administered will
protect more than 99 percent of dogs from infection. Most failures of protection
result from irregular and infrequent administration of the drug. However, the
monthly preventives all have a reasonable margin for error in their
administration such that if a single month's dose is accidentally missed,
adequate protection is usually provided so long as the next two monthly doses
are administered on schedule.
Cats may be treated with ivermectin (Heartgard for Cats), or the
topical selamectin (Revolution for Cats).
Monthly heartworm prevention should be administered beginning within a month
of the onset of the local mosquito season and continued for a month after the
cessation of local mosquito activity. In warm climates, such as the warm
temperate climate along the immediate Gulf coast of the United States and in
tropical and subtropical regions, heartworm prevention must be administered year
round. Some authorities recommend year round administration even in colder
climates on the theory that mosquito activity may occur during the occasional
unseasonable warm spell, but others argue that computer models indicate
heartworm transmission is highly unlikely under such circumstances.
Human health considerations
The dog heartworm is a negligible public health risk, because it is unusual
for humans to become infected. Additionally, human infections usually are of
little or no consequence, although rarely an infected human may show signs of
respiratory disease. In most cases, however, the heartworm dies shortly after
arriving in the human lung, and a nodule, known as a
granuloma,
forms around the dead worm as it is being killed and absorbed. If an infected
person happens to have a chest X-ray at that time, the granuloma may resemble
lung
cancer on the X-ray and require a
biopsy to rule
out the life threatening condition. This may well be the most significant
medical consequence of human infection by the dog heartworm.
At one time it was thought that the dog heartworm infected the human eye,
with most cases reported from the southeastern United States. However, these
cases are now known to be caused by a closely-related parasite of
raccoons,
Dirofilaria tenuis. Several hundred cases of
subcutaneous (under the skin) infections in humans have been reported in
Europe, but these are almost always caused by another closely-related parasite,
Dirofilaria repens, rather than the dog heartworm.
Resources and external links
-
American Heartworm Society Founded in 1974, the American Heartworm
Society is internationally recognized as the definitive authority with
respect to heartworm disease in dogs and cats.
American Heartworm Society Information for Pet Owners:
American Heartworm Society Information for Veterinarians. (Every three years
the American Heartworm Society holds an international symposium. Following each
triennial symposium, the Society updates its guidelines for veterinarians to
incorporate any new discoveries. The following guidelines are widely considered
"best practices" and should be closely followed by veterinarians in dealing with
this parasite.)
Other Resources
Home | Up | Heart Valve Dysplasia | Heartworm | Hemangiosarcoma | Hemivertebrae | Hip Dysplasia | Hyperthyroidism | Hypertrophic Osteodystrophy | Hypertrophic Osteopathy
Dogs, made by MultiMedia | Free content and software
This guide is licensed under the GNU
Free Documentation License. It uses material from the Wikipedia.
|